Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Sep 02, 2021 12:52pm
89 Views
Post# 33801139

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I'm In

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I'm InPorky - you're the only rookie here.
You can't even recall what I've been saying all these years and that in itself is a little sad.

"Careful."
"This moves sideways for a long time."
"The only effective way for me to play this ... is to accumulate over time."
"Goodman is asking for 10 years to build ROW."

How on earth can any of those be construed as "brainwashing?"
Hahaha - you are a funny little character.

---------------------

Management has built a heck of a ROW - but - if that's not your thing Porky ... you really shouldn't have been here in the first place.

I think Porky saw Revenue = $350K and Income = $120,000,000.00 in Knight's first year and he thought that was only going to continue to grow from there ... hahaha !

Actually - I shouldn't laugh - we did have people wonder why the 2nd year financials weren't as good as the first year's financials.  We get all kinds here!

----------------------

Anyway ... more importantly ... there was some data in the ROW product lists that I forgot to mention.  I'll add it under a separate message.

According to the three amigos here ... I have to put out more messages and make my quota if I want to get paid handsomely - It's hard work sometimes.


: )

<< Previous
Bullboard Posts
Next >>